Travis B. Lewis, Ph.D.

Affiliations: 
2012 Cell Biology University of Alabama, Birmingham, Birmingham, AL, United States 
Area:
Parkinson's disease
Google:
"Travis Lewis"
Mean distance: 16.35 (cluster 11)
 
SNBCP

Parents

Sign in to add mentor
David G. Standaert grad student 2012 UAB
 (Development of an adenoviral vector platform for selective gene delivery to neurons.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lewis TB, Glasgow JN, Harms AS, et al. (2014) Fiber-modified adenovirus for central nervous system Parkinson's disease gene therapy. Viruses. 6: 3293-310
Lewis TB, Standaert DG. (2011) Parkinson's disease, primates, and gene therapy: vive la différence? Movement Disorders : Official Journal of the Movement Disorder Society. 26: 2-3
Lewis T, Gendelman H. (2011) CCR5 chemokine receptor Xpharm: the Comprehensive Pharmacology Reference. 1-12
Lewis TB, Glasgow JN, Glandon AM, et al. (2010) Transduction of brain dopamine neurons by adenoviral vectors is modulated by CAR expression: rationale for tropism modified vectors in PD gene therapy. Plos One. 5
Lewis TB, Standaert DG. (2008) Design of clinical trials of gene therapy in Parkinson disease. Experimental Neurology. 209: 41-7
Boska MD, Lewis TB, Destache CJ, et al. (2005) Quantitative 1H magnetic resonance spectroscopic imaging determines therapeutic immunization efficacy in an animal model of Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 1691-700
Benner EJ, Mosley RL, Destache CJ, et al. (2004) Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America. 101: 9435-40
Boska MD, Mosley RL, Nawab M, et al. (2004) Advances in neuroimaging for HIV-1 associated neurological dysfunction: clues to the diagnosis, pathogenesis and therapeutic monitoring. Current Hiv Research. 2: 61-78
Xiong H, Zeng YC, Lewis T, et al. (2000) HIV-1 infected mononuclear phagocyte secretory products affect neuronal physiology leading to cellular demise: relevance for HIV-1-associated dementia. Journal of Neurovirology. 6: S14-23
See more...